Brain Cancer Vaccine's Immune Response Key to Outcomes - BusinessWeek
TUESDAY, July 15 (HealthDay News) — An in-trial dendritic cell vaccine that fights malignant brain tumors called glioblastoma multiforme (GBM) may help boost a patient's immunity response and improve the outcome, a new report says. An article in the

Pope speaks of his long journey Down Under in speech to thousands of - International Herald Tribune
SYDNEY, Australia : Australia is a long way away from pretty much everywhere. Pope Benedict XVI is one of the latest to find out. The 81-year-old pope, in his first major speech to the hundreds of thousands of pilgrims who have converged on Sydney

Novartis Second-Quarter Net Rises 17% on Diovan Sales (Update3) - Bloomberg
July 17 (Bloomberg) — Novartis AG , the maker of the Femara breast tumor treatment, said second-quarter profit rose 17 percent, more than analysts estimated, as it sold more of the Diovan heart pill and the Gleevec cancer medicine. Net income

Organ Transplants Linked to Cancer - HealthScout
(Ivanhoe Newswire) — Organ transplants can save lives, but new research shows they might also put recipients at risk of developing cancer. New research at the Harvard Medical School revealed the immunosuppressive drug cyclosporine ramps up vascular

MediGene Exercises Option for Anti-L1 Monoclonal Antibody and - Phramalive.com
MARTINSRIED/ MUNICH, Germany, July 17, 2008 (PRIME NEWSWIRE) — MediGene AG (Frankfurt:MDG) announced that, according to plan, an option, granted two years ago by the German Cancer Research Center (Deutsches Krebsforschungszentrum = DKFZ) in